Atlas Trials

Topotecan for Irinotecan-Refractory SCLC

Clinical trial NCT00502762 · UNKNOWN

Trial details

NCT number
NCT00502762
Sponsor
Gachon University Gil Medical Center
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Lung CancerRefractory to Chemotherapy
Start date
2004-09-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.